About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Blood-Thinning Medications Associated With Increased Risk of Bleeding

by Kanimozhi Tamilselvan on October 5, 2017 at 9:37 AM
Font : A-A+

Blood-Thinning Medications Associated With Increased Risk of Bleeding

Use of non-vitamin K oral anticoagulants with certain medications are associated with an increased risk of major bleeding, according to a study published by JAMA.

Oral anticoagulation has been proven to prevent ischemic strokes and prolong life for patients with atrial fibrillation. Non-vitamin K oral anticoagulants (NOACs) are being used more frequently because of their ease of administration and comparative efficacy compared with warfarin in reducing blood clots and major bleeding.

Advertisement


However, for patients with atrial fibrillation, NOACs are often prescribed with other medications that share metabolic pathways that may increase major bleeding risk.

Chang-Fu Kuo, M.D., Ph.D., of Chang Gung Memorial Hospital, Taoyuan, Taiwan, and colleagues used data from the Taiwan National Health Insurance database and included 91,330 patients with nonvalvular atrial fibrillation who received at least one NOAC prescription of dabigatran, rivaroxaban, or apixaban and estimated the bleeding risk associated with or without the concurrent use of 12 commonly prescribed medications that share metabolic pathways with NOACs (atorvastatin; digoxin; verapamil; diltiazem; amiodarone; fluconazole; ketoconazole, itraconazole, voriconazole, or posaconazole; cyclosporine; erythromycin or clarithromycin; dronedarone; rifampin; or phenytoin).
Advertisement

Among the patients in the study, 4,770 major bleeding events occurred. The researchers found that concurrent use of amiodarone, fluconazole, rifampin, and phenytoin with NOACs had a significant increase in incidence rates of major bleeding than NOACs alone.

Compared with NOAC use alone, the incidence rate for major bleeding was significantly lower for concurrent use of atorvastatin, digoxin, and erythromycin or clarithromycin and was not significantly different for concurrent use of verapamil; diltiazem; cyclosporine; ketoconazole, itraconazole, voriconazole, or posaconazole; and dronedarone.

The study notes some limitations, including that bleeding risk and anticoagulant treatment in the Asian population have been recognized to be different from the Western population. Therefore, the external generalizability of these results, particularly to a Western population may be limited.

"Physicians prescribing NOAC medications should consider the potential risks associated with concomitant use of other drugs," the authors write.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
First Dose of COVID-19 Vaccines May Improve Mental Health
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity von Willebrand Disease Hemophilia 

Recommended Reading
New Avenue for Developing Protective Blood Thinners Identified
New target could control stroke-causing thrombus formation, while retaining normal clotting ......
Delayed Use of Blood Thinners for Patients With Atrial Fibrillation Increases Dementia Risk
The risk of dementia in low-risk patients was 30% higher for those who received delayed treatment, ....
As-Needed Basis Blood Thinners Lower Stroke Risk Than Long-Term Use
Oral anticoagulation therapy is recommended in patients with infrequent atrial fibrillation and ......
New Type Of Blood Thinner More Effective In Preventing Stroke
Direct oral anticoagulant are blood thinning medicines which can reduce the risk of stroke in ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Hemophilia
Hemophilia is a rare single gene, X- linked disorder, which tends to run in families....
von Willebrand Disease
von Willebrand's Disease (vWD) is an autosomal dominant inherited bleeding disorder that occurs from...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use